Development of models estimating the risk of hepatocellular carcinoma after antiviral treatment for hepatitis C-Reference-Cited by-同舟云学术

Development of models estimating the risk of hepatocellular carcinoma after antiviral treatment for hepatitis C

Published:2018-11 Issue:5 Volume:69 Page:1088-1098
ISSN:0168-8278
Container-title:Journal of Hepatology
language:en
Short-container-title:Journal of Hepatology

Author:

Ioannou George N.,Green Pamela K.,Beste Lauren A.,Mun Elijah J.,Kerr Kathleen F.,Berry Kristin

Publisher

Elsevier BV

Subject

Hepatology

Reference48 articles.

1. HCV eradication induced by direct-acting antiviral agents reduces the risk of hepatocellular carcinoma;Ioannou;J Hepatol,2018

2. AASLD guidelines for the treatment of hepatocellular carcinoma;Heimbach;Hepatology,2018

3. Bruix J, Sherman M. AASLD Practice guideline. Management of hepatocellular carcinoma: an update. Available at: http://www.aasld.org/sites/default/files/guideline_documents/HCCUpdate2010.pdf; 2011.

4. Management of hepatocellular carcinoma;Bruix;Hepatology,2005

5. Diagnostic per-patient accuracy of an abbreviated hepatobiliary phase gadoxetic acid-enhanced MRI for hepatocellular carcinoma surveillance;Marks;AJR Am J Roentgenol,2015

Cited by 117 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Regional Differences in Clinical Presentation and Prognosis of Patients With Post–Sustained Virologic Response Hepatocellular Carcinoma;Clinical Gastroenterology and Hepatology;2024-01

2. Predictive models for hepatocellular carcinoma development after sustained virological response in advanced hepatitis C;Gastroenterología y Hepatología;2023-12

3. Predictive models for hepatocellular carcinoma development after sustained virological response in advanced hepatitis C;Gastroenterología y Hepatología (English Edition);2023-12

4. Risk Stratification Model for Hepatocellular Cancer in Patients With Cirrhosis;Clinical Gastroenterology and Hepatology;2023-12

5. Accurate prediction of HCC risk after SVR in patients with hepatitis C cirrhosis based on longitudinal data;BMC Cancer;2023-11-25